Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
ANOS1	ADMLX, KAL, KAL1, KALIG-1, WFDC19	ENSG00000011201	Anosmin 1	P23352	X	8528874-8732186	Disease related genes, Predicted secreted proteins	Cell adhesion, Chemotaxis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.5;lung: 37.1;parathyroid gland: 27.7	Cell type enriched	Detected in many	6	Alveolar cells type 1: 223.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3														Secreted in brain								unprognostic (2.93e-1)	unprognostic (5.33e-2)	unprognostic (9.54e-2)	unprognostic (4.16e-3)	unprognostic (7.77e-3)	unprognostic (1.58e-1)	unprognostic (1.55e-2)	unprognostic (1.17e-3)	unprognostic (4.53e-2)	unprognostic (6.43e-2)	unprognostic (2.09e-2)	unprognostic (6.24e-2)	unprognostic (1.71e-2)	unprognostic (9.38e-3)	unprognostic (6.77e-2)	unprognostic (1.63e-1)	unprognostic (3.56e-2)	5.4	4	13.8	1.3	14	0.6	3.6	1.3	18	4.5	1	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6	0.9	0.8	27.7	1	1.4	19.3	4.1	1.3	6	2.8	4.5	10.9	3	0.9	1.1	25.5	1.1	1.1	5	8.5	1.3	8.5	1	1.2	1.6	1.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	1.4	0.5	0	0.7	0.1	0	0	0	0	0	0	2.5	0	0.4	2.6	0.1	3.5	0.3	3.8	0	0	0	1	0	1.9	0.2	0.1	25.9	0	0	0	0	0.3	0.2	0.1	0	23.4	0	0	0	0	0	1.3	0.4	1.3	0	1.1	0.3	0	3.2	0	0.6	0	0	11.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.8	14	1.3	7.6	11.1	7.9	5.7	6	19.3	8.5	223.4	9.3	0	4.2	0	6.4	6.2	0	6.7	36.4	0	3.9	0.1	0	0	0.2	0.5	0	0	0	0.2	1.5	2.9	1.1	0	5.2	0	0	2.5	2.2	0	0.6	1.4	0	0	0	21.4	0.8	0	1.1	0	1.5	0	0.3	0.3	0.7	0	0.1	0	0.1	0.8	Alveolar cells type 1
CLDN18	SFTPJ	ENSG00000066405	Claudin 18	P56856	3	137998735-138033655	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	41	gallbladder: 37.4;lung: 91.9;stomach 1: 126.9	Cell type enriched	Detected in some	5	Alveolar cells type 1: 1488.8	Group enriched	Detected in some	11	pancreatic cancer: 113.7;stomach cancer: 186.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	OE19: 18.9	Not detected	Not detected			Not detected	Not detected			CAB013010, CAB013243, HPA018446	Enhanced		Approved	Cell Junctions						Cell Junctions		CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866	unprognostic (1.03e-1)	unprognostic (1.49e-1)	unprognostic (2.93e-1)	unprognostic (1.04e-2)	unprognostic (1.41e-1)	unprognostic (8.51e-2)	unprognostic (5.14e-4)	unprognostic (2.00e-1)	unprognostic (1.29e-1)	unprognostic (2.60e-1)	unprognostic (9.54e-2)	unprognostic (1.38e-2)	unprognostic (4.42e-5)	unprognostic (1.66e-1)	unprognostic (2.26e-1)	unprognostic (8.26e-2)	unprognostic (2.95e-1)	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2	0.1	0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.2	0	0.4	0.1	0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0	0.5	0	0.3	0.1	0	0.2	0	0.7	0	0	0	0.9	0.3	0.1	0.1	0.2	0.5	0	0	0	0.1	0	0.1	0.5	0.1	0.6	18.9	0.1	0.4	0	0	0	0.3	0.1	0.1	0.1	0	0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0.4	0	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.5	0.1	1488.8	318.5	0	0	0	0.8	18.9	0	1.4	20.5	0	0	0	0	0.3	0.2	0	0	0	9.9	0	0	0.1	4.7	0	0	0	0	0	0	0.4	0	0.3	0	0	0	0	257.5	0	0	0	1.4	0	0	6.6	3.8	0	0	0	0	0	Alveolar cells type 1
SLCO1A2	OATP, OATP-A, OATP1A2, SLC21A3	ENSG00000084453	Solute carrier organic anion transporter family member 1A2	P46721	12	21264600-21419594	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5	Cell type enriched	Detected in some	9	Alveolar cells type 1: 32.8	Cancer enhanced	Detected in some		testis cancer: 2.5	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0					Low region specificity	Detected in all			HPA071152			Supported	Plasma membrane		No	No			Plasma membrane		HPA071152: AB_2686350	unprognostic (5.43e-3)	unprognostic (2.33e-1)	unprognostic (1.28e-1)	unprognostic (8.59e-2)	unprognostic (1.08e-1)	unprognostic (6.36e-2)	unprognostic (7.63e-2)	unprognostic (1.53e-1)	unprognostic (3.82e-2)	unprognostic (1.54e-2)	unprognostic (1.51e-1)	unprognostic (8.82e-2)	unprognostic (1.66e-4)	unprognostic (2.52e-2)	unprognostic (3.20e-1)		unprognostic (1.24e-1)	0.2	0.1	3.3	0	3.4	0	3.6	3.4	17.9	0.1	0.1	1.9	0	0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3	4	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0	14.2	14.5	0	0.4	0.4	0.2	0	2.9	0.4	0.4	1.6	1.4	0	0.3	0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2	0.5	0.8	0.2	0	0	2.7	0	0	0	0	2.9	1.7	0.1	2.1	0.1	0	0.2	0.2	0.1	0.4	0.5	0.7	0	0.4	1.1	0	0.3	0.2	0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0	2	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0	2	1.8	2.3	0	0.2	0.2	14.2	2.6	0.7	0	0	1.4	0.6	0.3	19.8	8	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5	4.1	2.5	3	4	9.7	1.4	32.8	1.9	0	0	0	0	0.4	0	2.7	0	1.8	0	0.1	0	0	3.5	0	0	0	0	0.4	0.3	0	0	0.4	0.1	0	0	0	0	2.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0.9	0	0.1	0	0	0	Alveolar cells type 1
ARHGEF26	DKFZP434D146, SGEF	ENSG00000114790	Rho guanine nucleotide exchange factor 26	Q96DR7	3	154121003-154257827	Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Alveolar cells type 1: 315.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		RH-30: 10.0;U-251 MG: 18.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017722, HPA049195	Approved		Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA017722: AB_1856800, HPA049195: AB_2680671	unprognostic (1.41e-1)	unprognostic (1.43e-3)	unprognostic (3.55e-1)	unprognostic (7.99e-3)	unprognostic (2.82e-1)	unprognostic (9.42e-3)	prognostic favorable (9.74e-4)	unprognostic (7.06e-2)	unprognostic (1.16e-1)	unprognostic (6.01e-5)	unprognostic (1.44e-3)	unprognostic (4.36e-2)	unprognostic (2.22e-1)	unprognostic (5.53e-3)	unprognostic (3.11e-1)	unprognostic (1.07e-1)	unprognostic (5.24e-3)	11.2	4	9.1	5.8	8.7	1	9.8	5.6	17.8	9.2	20	6.5	3.3	10.3	5.9	3.1	12	8.3	17.6	4.1	8.7	4.6	3.1	22	18.6	1	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0	4.1	2.5	2	7.4	11.4	0	0.3	0	0.5	0	0.1	0	5.3	3.1	6.1	4.2	2.7	0.4	0.1	0.3	0	1.6	1.8	2.5	0.4	2.5	0.4	0.1	2.8	6.3	3.1	1.5	2.8	0	8.1	0	2.3	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.9	0.1	2.6	0	0	1	6.2	1.1	0.1	3.9	1.2	2.7	0	10	0	0.5	3.5	2.3	0.7	0.7	8.8	1.3	3.3	5.4	0.4	0	0.9	4	0	18.1	2.6	0.4	0	1.6	0	6.2	0	0.1	0	0	0.5	0	0	0	0	0.3	0	0.1	0	0	0	0.1	0	0	0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5	315.6	29.8	0.9	7.9	17.3	9.4	1.2	20.4	21.4	17	3.5	3.9	1.4	0	1.9	9.1	3	2.6	0	2.2	1	8.1	6.7	4.7	44.5	0.6	4.8	0	8.6	2.8	1.7	9.8	0.9	3.3	1.8	4.5	70.3	1.7	2.9	17.7	0	50.2	0	4.2	2.9	32.4	20.7	5.1	5.7	1.7	5.3	Alveolar cells type 1
EPB41L5	BE37, FLJ12957, KIAA1548, YMO1, YRT	ENSG00000115109	Erythrocyte membrane protein band 4.1 like 5	Q9HCM4	2	120013005-120179119	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Alveolar cells type 1: 202.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 25.1;MCF7: 37.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA037563, HPA037564	Uncertain		Enhanced	Plasma membrane						Plasma membrane		HPA037563: AB_2675546, HPA037564: AB_2675547	unprognostic (1.27e-2)	unprognostic (2.15e-1)	unprognostic (2.56e-2)	unprognostic (2.31e-1)	unprognostic (3.33e-2)	unprognostic (1.47e-2)	unprognostic (1.53e-1)	unprognostic (9.06e-3)	unprognostic (5.93e-2)	unprognostic (8.76e-2)	unprognostic (2.20e-2)	unprognostic (9.51e-2)	prognostic favorable (2.28e-6)	unprognostic (1.99e-1)	unprognostic (3.88e-1)	unprognostic (9.59e-2)	unprognostic (2.61e-1)	4.6	5	7.4	6	11.6	1.1	13.3	19.4	12.6	7.4	8.6	6.9	4.3	10.6	7.2	4.9	7	10.2	6.2	4.9	8.5	7.4	25.6	42.3	36.3	3.8	7.6	6.5	9.4	20.3	13	15.8	7.5	12.2	9.9	7	7.1	10.8	6.6	8.6	6.6	9.5	7.5	14.8	2.2	7	22	6.1	2.9	25.2	6.4	5	5.3	8.4	4.7	0.4	1.8	1.4	1.5	3.2	1.4	8	2.7	11.2	8.6	7.8	5.7	9.7	1.7	1.7	3.6	3.3	25.1	5.4	0.1	6.1	2.1	4.6	5.5	15	6.8	5.4	1.6	4.6	2.3	1.3	14	9.1	1	2.5	5.1	13	6.8	4.9	3.2	10.2	4.8	5.4	0.6	7.2	37.6	1.9	3.5	10	3.7	2.6	0	3.3	2.2	11.4	7.8	5.8	11.1	7.6	13.5	3.7	16	6.5	1.9	8.4	0.3	5.4	5.7	1.7	0.8	1.5	4.2	0.9	0	2.1	0.3	1.4	1.5	1.1	0.3	0.3	4.7	1.2	1.1	0.4	3.6	3.2	2.4	1.8	1.5	0.9	0	0.5	1.4	7.4	11.6	19.4	12.6	8.5	7.4	7.6	6.5	12.2	6.1	202.5	30.3	2.9	19.7	21.8	31.4	12	15.3	20.1	25	31.4	23.6	11.9	18.3	15.8	22.4	5.8	17.7	0	19.5	10	13.3	24	0	47.8	2.7	7.9	14.9	16.5	1.9	16.2	8.3	3.3	13.5	1	10.2	18.1	20.4	17.3	8.9	23.7	33.6	19.4	7.7	33.8	43.9	19.1	22.1	2.5	9.7	30.4	Alveolar cells type 1
PCYOX1	KIAA0908, PCL1	ENSG00000116005	Prenylcysteine oxidase 1	Q9UHG3	2	70257386-70281191	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Alveolar cells type 1: 556.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 80.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035193	Approved				Intracellular and membrane				480000000			HPA035193: AB_10602017	unprognostic (1.09e-1)	unprognostic (1.72e-2)	unprognostic (7.91e-2)	unprognostic (1.15e-2)	unprognostic (1.44e-1)	unprognostic (2.05e-1)	unprognostic (6.87e-2)	unprognostic (6.28e-2)	unprognostic (1.14e-1)	unprognostic (1.80e-1)	unprognostic (1.61e-1)	unprognostic (4.38e-2)	prognostic favorable (1.89e-4)	unprognostic (3.26e-2)	unprognostic (1.55e-1)	unprognostic (1.13e-1)	unprognostic (1.54e-2)	36.6	20.6	12.9	13.5	17	2.1	21.7	12.5	19.7	32.2	20.1	13.2	27.2	12.9	31.3	26.5	24.5	23	26.5	22.5	12.3	24.1	48.9	53.3	29.2	10.6	14.9	17.4	22.1	12.9	47.7	29.8	18.8	23.2	24.2	12.8	30.5	55.8	31.4	42	17.2	18.3	24.6	13.8	10.8	17.3	11.3	10.8	5	31.8	22.8	13.7	24.5	23.1	4.6	8.4	13.5	7.2	6.6	13.4	6.8	9.2	13.4	10.8	12	80.3	41.4	9.5	15.9	14.7	8.9	6.7	21	8.3	0.9	6.9	21.7	14.6	15.3	7.8	12.3	10.2	5.3	6.6	3.5	10.5	18.2	8	3.3	3.2	39.7	13.6	11.8	3.3	23.7	10.5	3.4	6.3	6.9	12.5	5.6	2.4	5.4	6.5	13.5	5.7	4.7	22.5	8.2	12.6	10.4	2.8	6	23.9	11.8	11.1	16	9.6	4.3	13	15	8.4	13.2	8.2	5.7	12.8	1.2	18	4.6	5.4	13.5	7.2	7.4	10	6.3	12.5	4.6	9.8	8.1	6.7	3.7	13.4	11.2	5	6.6	6.4	8.4	8.6	6.8	12.9	17	12.5	19.7	12.3	24.1	14.9	17.4	23.2	10.8	556.9	69.3	10.4	20.6	18.9	44.9	69	38.2	22.7	48.9	50.6	41.2	33.8	6.6	21.9	1.4	32.9	23	0	8.9	29.3	41.9	33.6	9.3	137.7	18.8	54	8.2	36.2	16.7	2	82.6	10.9	23.6	5.4	24.2	94.5	14	26.9	113.5	50.9	29.8	71.1	35	4.9	30.4	24.7	18.4	11.7	20.7	15.9	Alveolar cells type 1
ST6GALNAC5	MGC3184, SIAT7E, ST6GalNAcV	ENSG00000117069	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	Q9BVH7	1	76867441-77065711	Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.4	Cell type enriched	Detected in some	7	Alveolar cells type 1: 50.6	Cancer enhanced	Detected in many		ovarian cancer: 10.9	Group enriched	Detected in many	4	amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA065593, HPA070354	Uncertain		Approved	Vesicles	Intracellular and membrane					Vesicles		HPA065593: AB_2685515, HPA070354: AB_2686260	unprognostic (1.32e-1)	unprognostic (5.96e-2)	unprognostic (1.72e-1)	unprognostic (1.49e-2)	unprognostic (2.82e-2)	unprognostic (2.04e-2)	unprognostic (4.67e-2)	unprognostic (2.72e-2)	unprognostic (3.60e-2)	unprognostic (1.99e-1)	unprognostic (1.61e-2)	unprognostic (1.58e-1)	unprognostic (2.10e-2)	unprognostic (5.90e-3)	unprognostic (9.66e-2)	unprognostic (6.88e-2)	unprognostic (1.69e-2)	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1	2.1	10.2	0.8	1	3.7	1.2	0.2	0	0.6	0	1.4	4.2	1.6	0	0	0	0	0	0.1	0.4	2.4	0	9.1	0	0	0	0	0.8	3.2	2.6	0.8	0	0.2	0	0	10.9	0	5.2	0	0.1	2.8	0	0.2	0	0	0	1.6	0	0	0.2	0.1	0	0.6	0	0	0	0	0	1.7	0	0	0	3.6	0	0	0	0.7	0.6	0	0.1	2.5	7.9	0	0	0	0.2	0	0	0	1.3	9	0	5	0	0.2	0	0.3	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3	14.2	4.7	0.2	50.6	0.3	0	0	0	7.3	0.4	0	1.4	1.2	0	0	0.1	0	0	2.1	0	0	0	0	0.1	0.6	0.1	1.1	0	0.1	0	0	0	0	1.1	0.6	0	0	0	0	0.5	0	0	0	0	1.4	0	0.3	0	0.5	0	0.1	0	0	0.1	Alveolar cells type 1
CNTN6	NB-3	ENSG00000134115	Contactin 6	Q9UQ52	3	1092576-1404217	Predicted membrane proteins	Cell adhesion, Notch signaling pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 41.4;thyroid gland: 18.9	Cell type enriched	Detected in some	6	Alveolar cells type 1: 32.8	Group enriched	Detected in some	15	renal cancer: 2.7;thyroid cancer: 3.2	Region enriched	Detected in many	5	cerebellum: 41.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	45	AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016645	Uncertain								2100000			HPA016645: AB_1847149	unprognostic (1.09e-1)	unprognostic (3.70e-1)		unprognostic (2.27e-1)	unprognostic (3.99e-1)	unprognostic (3.16e-1)	unprognostic (1.05e-4)	unprognostic (1.45e-1)	unprognostic (1.86e-1)	unprognostic (3.80e-2)	unprognostic (2.61e-2)	unprognostic (4.65e-2)	unprognostic (1.26e-3)	unprognostic (5.45e-2)	unprognostic (5.23e-2)	unprognostic (1.15e-1)	unprognostic (4.46e-2)	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0	18.9	0	0.2	0.3	0.1	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	2.2	41.4	6.3	1.5	3	2.4	2.6	7.8	0.3	32.8	2.2	0	0	0	2.6	0.4	0	1.4	5.7	0	0	0.2	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	1.1	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.5	0	0	0	Alveolar cells type 1
SCEL	FLJ21667, MGC22531	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 145.6;skin 1: 70.8;tongue: 62.2	Cell type enriched	Detected in many	13	Alveolar cells type 1: 631.3	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3	Low region specificity	Detected in many			Not detected	Not detected			HPA039737, HPA040154	Enhanced		Supported	Nucleoplasm,Plasma membrane,Cytosol		No	No			Plasma membrane	Nucleoplasm, Cytosol	HPA039737: AB_10805485, HPA040154: AB_10795359	unprognostic (1.18e-1)	unprognostic (1.17e-1)	unprognostic (2.00e-1)	prognostic unfavorable (4.07e-4)	unprognostic (5.91e-2)	unprognostic (4.54e-2)		unprognostic (6.62e-2)	unprognostic (3.51e-1)	unprognostic (8.08e-3)	prognostic unfavorable (1.24e-4)	unprognostic (4.57e-2)	prognostic favorable (6.87e-4)	unprognostic (1.81e-1)	unprognostic (2.82e-1)	unprognostic (1.75e-3)	prognostic unfavorable (1.73e-5)	0.4	0	0.1	0.2	0.4	0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0	0.8	0.2	145.6	0	0.3	0.1	0.1	0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0	0	0	0	0	0	0	6.9	0.1	0	0	0	0	0	0	0	0	0	0	12.4	0	0.7	0	0	23.3	0	11.1	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0	0	0	0	31.1	6.3	0	0	0	45.3	0	1	0	0	0.6	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	631.3	30.6	0	0	9.5	0	0.2	0	6.7	42.1	0	0	0.3	0	4.1	5.8	0	0	0	0.2	0	0.3	0.1	1.1	0	0	0	0	0	0	12.4	0	0.6	1.7	0	4.3	1.5	26.6	0	0	0	0	0	0	1.7	2.7	48.8	0.1	0	0	2.6	Alveolar cells type 1
WWC2	BOMB, FLJ22029	ENSG00000151718	WW and C2 domain containing 2	Q6AWC2	4	183099293-183320777	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Alveolar cells type 1: 244.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Group enriched	Detected in many	5	monocytes: 1.9;T-cells: 2.1	Cell line enhanced	Detected in many		SiHa: 33.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044005	Uncertain		Approved	Microtubules						Microtubules		HPA044005: AB_10960552	unprognostic (1.07e-1)	prognostic unfavorable (8.61e-4)	unprognostic (7.16e-4)	unprognostic (1.70e-1)	unprognostic (2.00e-2)	unprognostic (4.48e-3)	unprognostic (2.05e-1)	unprognostic (3.93e-2)	unprognostic (4.42e-2)	unprognostic (1.97e-1)	unprognostic (9.52e-3)	unprognostic (2.22e-1)	prognostic favorable (9.29e-4)	unprognostic (3.27e-2)	unprognostic (3.44e-1)	unprognostic (3.23e-1)	unprognostic (2.52e-2)	10.8	6.7	8.2	4.8	9.1	0.9	12.3	3.5	7.4	11.6	8.5	8.6	9.8	2.4	17.6	7.1	6.7	8.6	9.7	12.3	9.6	4.8	20.3	19.9	28.8	3.3	10	7.2	12.8	13.1	15.5	5.9	14.9	9.1	8.9	3.4	16.5	11.3	9.9	5.5	5.4	4	11.2	9.9	6.4	8.9	15.4	8.5	0	16.8	4.5	3.1	9.8	17	0	0.4	0	1.9	0.4	2.1	0.3	10.1	4.3	9.4	8.4	7.1	7.9	10.9	13.8	11	15.3	11	19.1	9.9	0	7	22.2	5.3	3.7	14.5	5.7	19.5	0	4.4	10.3	10	9.8	7.3	4.8	11.4	6	4.4	10.1	9.5	12.7	10.1	1.5	7.3	0.5	11.6	2.9	0	3.2	9	0.3	3.7	0	8.6	5.5	21.8	2.7	0.6	4.8	33.8	29.7	4.4	15.7	7.2	1.6	15.1	5.7	16	3.3	9.9	0	0	0.1	5.6	2.2	10	0	1.4	0	0.6	1.1	1	0	0.6	0.2	0.4	0	2.1	0.6	0	0.4	1.9	0	0	0.3	8.2	9.1	3.5	7.4	9.6	4.8	10	7.2	9.1	8.5	244.2	50.8	0	6.7	21.3	3.2	25.8	43.3	14.7	37.5	7	60.9	11.9	23.2	13.2	30.2	20.4	0	0	12.4	7.5	16.9	19.6	18.5	33.7	8.5	0	1.2	16.5	13.1	16.8	16.4	7.1	11.8	7.2	0.1	11.8	23	0	19.8	19	60.1	25.8	18	29.8	16.8	13.4	5.5	1	0.1	7.6	Alveolar cells type 1
ITLN2	HL-2	ENSG00000158764	Intelectin 2	Q8WWU7	1	160945025-160954799	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	intestine: 88.4	Cell type enriched	Detected in some	9	Alveolar cells type 1: 71.5	Cancer enhanced	Detected in many		testis cancer: 4.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4									HPA006683, HPA067326	Enhanced				Secreted to digestive system							HPA006683: AB_2129681, HPA067326: AB_2732764		unprognostic (1.42e-1)	unprognostic (9.62e-3)	unprognostic (4.61e-2)	unprognostic (7.45e-2)	unprognostic (2.25e-1)	unprognostic (6.84e-4)	unprognostic (2.47e-2)	unprognostic (5.74e-2)	unprognostic (1.31e-2)	unprognostic (1.36e-1)	unprognostic (5.01e-1)		unprognostic (1.84e-1)	unprognostic (1.49e-1)	unprognostic (2.31e-1)	unprognostic (4.91e-2)	3	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	1.4	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	15.4	0	0	2.6	0	4.6	0	1.5	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0.6	0	0	0	1.5	0	0	0	1	0	0	4.9	5.4	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	71.5	7.7	0	0.4	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0.6	0	0	0.1	0	0	8	0	0	1.1	0	0	0	3.1	0	0	0	4.9	0	0	0	0	0	0.1	0	0	0	0.1	0.1	Alveolar cells type 1
MS4A15		ENSG00000166961	Membrane spanning 4-domains A15	Q8N5U1	11	60756953-60776732	Predicted membrane proteins		Receptor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	9	blood: 9.9;lung: 32.4	Cell type enriched	Detected in some	8	Alveolar cells type 1: 89.3	Cancer enhanced	Detected in many		lung cancer: 6.3	Not detected	Not detected			Cell type enhanced	Detected in some		T-reg: 9.9	Lineage enriched	Detected in single	15	T-cells: 9.9	Cell line enhanced	Detected in some		HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7	Region enriched	Detected in single	28	olfactory region: 205.0	Region enriched	Detected in single	30	olfactory region: 39.1	HPA054563			Approved	Plasma membrane,Cytosol						Plasma membrane	Cytosol	HPA054563: 	unprognostic (1.85e-1)	unprognostic (4.31e-3)	unprognostic (8.59e-2)	unprognostic (5.89e-4)	unprognostic (4.49e-1)	unprognostic (1.09e-3)		unprognostic (3.92e-3)	unprognostic (5.43e-3)	unprognostic (1.20e-1)	unprognostic (7.30e-2)	unprognostic (3.14e-1)	unprognostic (1.04e-9)	unprognostic (7.02e-2)	unprognostic (8.63e-2)	unprognostic (2.75e-1)	unprognostic (1.47e-1)	0.3	0.2	0.3	0.3	0.3	0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1	0.7	0.3	0.2	0	0	0	0.6	9.9	0.7	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	1.6	0.1	0	0	0	0	0	0.2	0.1	9.2	0	0	0	0.1	0.2	0.1	0	0	0	0	0	3.4	1.6	3.8	0	0	4.1	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.3	1.1	0	0	0	0.5	0	0	13.5	5.7	0.9	0.1	0	0	0	0	0	0.1	0	0.1	0.2	2.9	0.5	0	0	1.8	0.7	0	0.6	0	0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	89.3	4.8	0	0	0	0	0.2	0	2.7	11.4	0	0	0.7	0	0	4.7	0	0	0	0	2.2	0	0	1.1	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.9	0	1.7	0	0	0	Alveolar cells type 1
CST5		ENSG00000170367	Cystatin D	P28325	20	23875935-23879750	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Thiol protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	268	salivary gland: 1065.3	Cell type enriched	Detected in single	22	Alveolar cells type 1: 8.9	Cancer enriched	Detected in many	5	breast cancer: 17.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.1;RPTEC TERT1: 3.6;RT4: 1.9;SuSa: 2.3;U-2 OS: 1.6									CAB024944, HPA061449	Enhanced				Secreted to digestive system							CAB024944: , HPA061449: AB_2684523	unprognostic (2.43e-1)		unprognostic (8.83e-2)	unprognostic (3.20e-1)	unprognostic (3.19e-1)			unprognostic (1.51e-2)	unprognostic (4.73e-1)	unprognostic (4.31e-2)	unprognostic (1.76e-2)	unprognostic (2.32e-1)	unprognostic (1.35e-1)	unprognostic (4.83e-3)		unprognostic (5.14e-2)	unprognostic (2.31e-1)	0	3.9	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0.9	0	3.8	0	0	0	0	1.5	0	0.1	0	0	0.6	0	0	1065.3	0	0	0	0.2	0.1	0	0	0	0.1	0	0	0	0.5	0.8	0.1	0	0	0.3	0	0.3	0	0.9	0.5	0.1	0	0	0	0	0	0	0	0.4	0	0	0	1.1	0	0	0	0	0.5	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.5	0	0	0	0	0	0	0	3.6	1.9	0	0	0	0	0.6	2.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.2	0	0.7	0.3	0.8	0	0.6	0.9	0.3	0	0	0.5	0	0	0.1	0.2	0	0.5	0	0	0.1	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0.3	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	Alveolar cells type 1
AQP4	MIWC	ENSG00000171885	Aquaporin 4	P55087	18	26852038-26865818	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 185.1;lung: 53.5	Cell type enriched	Detected in some	4	Alveolar cells type 1: 1024.3	Cancer enriched	Detected in some	22	glioma: 223.7	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB005079, HPA014784, CAB058689	Enhanced	Supported	Supported	Plasma membrane,Cell Junctions						Plasma membrane	Cell Junctions	CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967	unprognostic (7.23e-5)	unprognostic (1.55e-1)		unprognostic (3.19e-8)	unprognostic (3.68e-1)	unprognostic (1.96e-1)	unprognostic (2.69e-2)	unprognostic (1.74e-1)	unprognostic (2.34e-1)	unprognostic (5.38e-3)	unprognostic (1.64e-3)	unprognostic (8.98e-2)	unprognostic (1.22e-1)	unprognostic (4.14e-2)	unprognostic (1.35e-1)	unprognostic (4.10e-2)		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0	1.6	1.6	2	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0	8.4	0.1	1.6	1.6	0.1	0	0	0	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1	0	0	0	0	0.2	0	0.1	0.5	0	0	0.5	0	0	0	0	0	0	0	0	2	0	0	0.5	0.2	0.9	0	0	0	0	0	3.9	0	1.3	0.3	0	0	0	0.1	0.3	0	0	0	0	0.3	0	0	0	0	1.8	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0	0.6	0	2.1	8.5	0	37.5	138.8	3.5	5.9	0	3.3	0.3	0	0	0	0	0	0	0.2	0.5	3.5	0.5	0	1.6	0	0	0	0	4.6	0	0	0	0	224.7	0	0	0	0	4.9	0	0	0	0	0	0.1	0	0	1.6	Alveolar cells type 1
ZBED2	MGC10796	ENSG00000177494	Zinc finger BED-type containing 2	Q9BTP6	3	111592900-111595443	Predicted intracellular proteins, Transcription factors				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	lymphoid tissue: 21.0;thyroid gland: 74.5	Cell type enriched	Detected in some	5	Alveolar cells type 1: 41.7	Cancer enriched	Detected in many	5	thyroid cancer: 64.0	Region enriched	Detected in single	6	basal ganglia: 1.4	Cell type enhanced	Detected in many		naive B-cell: 4.0	Group enriched	Detected in many	6	B-cells: 4.0;T-cells: 2.5	Group enriched	Detected in some	5	CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0					Not detected	Not detected			HPA029786			Approved	Nuclear bodies,Mitochondria,Cytosol		No	No			Mitochondria, Cytosol	Nuclear bodies	HPA029786: AB_10601028	unprognostic (7.31e-3)	unprognostic (1.67e-1)	unprognostic (1.98e-3)	unprognostic (1.66e-1)		unprognostic (2.39e-3)	unprognostic (3.49e-1)	unprognostic (7.61e-2)	unprognostic (1.47e-1)	unprognostic (2.84e-1)	prognostic unfavorable (8.83e-4)	unprognostic (2.59e-1)	unprognostic (1.47e-6)	unprognostic (3.81e-2)	unprognostic (4.34e-1)	unprognostic (4.69e-2)	unprognostic (3.29e-2)	0.1	0	0.1	0.9	1.4	0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0	0.4	4	0.1	0.1	0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21	74.5	7.5	7.4	0.2	6.2	4	0	0.1	0	0.5	2.5	0.3	5.4	0	0	0	0	0	0	0	0	0	0	0	20.1	0.1	14	0	0	19.4	0	43.6	0	0	0	0	0.3	0	0	0	0	0	4	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	1.4	0	1	3.6	0.6	0.3	0	4	1.9	2.5	0.1	0.5	0	0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	41.7	1.4	0	0.2	3.9	0	0	0	0	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	3.3	0	0.7	0	0.1	Alveolar cells type 1
SERTM1	C13orf36	ENSG00000180440	Serine rich and transmembrane domain containing 1	A2A2V5	13	36673912-36697839	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3	Cell type enriched	Detected in some	5	Alveolar cells type 1: 8.9	Cancer enhanced	Detected in some		ovarian cancer: 3.7	Group enriched	Detected in many	7	amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA054814, HPA070485	Uncertain		Enhanced	Vesicles						Vesicles		HPA054814: AB_2682611, HPA070485: AB_2686272	unprognostic (8.71e-2)	unprognostic (2.11e-1)		unprognostic (5.58e-3)	unprognostic (4.66e-3)			unprognostic (4.05e-3)		unprognostic (5.06e-2)	unprognostic (2.79e-2)	unprognostic (1.63e-2)	unprognostic (1.00e-8)	unprognostic (2.51e-2)	unprognostic (5.60e-2)	unprognostic (4.44e-2)		5	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0	0	9.3	0	0.5	1.1	6.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.7	0	0	0	3.2	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0.4	4.7	0	0	0	0.8	0	0	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9	10.1	0.3	21.6	26.5	2	1.5	11.6	2.4	0	8.9	0	0	0	0	1	0.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	1.6	0	0	0	0	0.3	0	1.7	0	0	0	0	0	0	0	1	0	0.1	0	0.4	0	0	0	0	0	Alveolar cells type 1
RTKN2	bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1	ENSG00000182010	Rhotekin 2	Q8IZC4	10	62183035-62268707	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	lung: 67.6	Cell type enriched	Detected in many	4	Alveolar cells type 1: 1628.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in some	7	T-reg: 15.4	Lineage enriched	Detected in single	47	T-cells: 15.4	Cell line enhanced	Detected in many		A-431: 25.5;HaCaT: 20.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA037946, HPA038446	Enhanced		Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA037946: AB_10795398, HPA038446: AB_10796218	unprognostic (2.33e-1)	unprognostic (2.59e-1)	unprognostic (2.52e-2)	unprognostic (1.52e-2)	unprognostic (1.26e-1)	unprognostic (8.92e-3)	unprognostic (6.66e-5)	unprognostic (7.81e-3)	unprognostic (2.33e-2)	unprognostic (3.24e-1)	unprognostic (3.72e-2)	unprognostic (9.48e-4)	unprognostic (3.70e-11)	unprognostic (3.95e-2)	unprognostic (9.34e-3)	unprognostic (4.68e-3)	unprognostic (1.55e-1)	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3	0.3	0.2	0.3	0.1	0.2	15.4	0.2	25.5	1.4	13.7	6.3	0	0.1	3.3	3.7	4.3	4.2	6.7	10.6	5.1	0.1	1.6	1.4	4.3	20.5	7.6	0.6	4.4	3.6	5.2	4.2	3.1	4.4	0	5.7	3.3	0.2	0.3	5.2	0.5	2.3	0.6	6.8	0.2	0.2	5.6	3.2	11	7.3	5.8	3.8	5.2	9.5	14.6	0	2.7	11.1	7.5	8.6	2.4	8.6	3.5	4.2	7.8	3.1	0	1.9	12.5	0.1	9.3	0.1	0	9.8	2.5	0	3	0.1	0.1	0.1	1.3	0	0.1	0.1	2.1	0.4	0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1	1628.8	44.5	0.9	8.3	4.1	0.6	0.4	0	4	15.9	0	0	3	0	1.4	376.8	0.1	0.4	0	1.4	4.9	2.5	7	3.5	0	2.1	0	1.7	1.8	0.6	65.6	2	2.2	1.7	0	5.9	0.4	9.1	0	1.8	1.4	0.5	0	1.9	21.3	23.6	1.6	1.7	12.7	3.3	87.2	Alveolar cells type 1
CYP4Z1	CYP4A20	ENSG00000186160	Cytochrome P450 family 4 subfamily Z member 1	Q86W10	1	47067488-47118319	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	breast: 23.1	Cell type enriched	Detected in some	4	Alveolar cells type 1: 8.9	Cancer enriched	Detected in some	50	breast cancer: 42.3	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	39	HDLM-2: 13.7;SK-BR-3: 5.9																						unprognostic (4.11e-2)	unprognostic (2.57e-2)	unprognostic (2.46e-1)	unprognostic (5.12e-2)	unprognostic (1.37e-1)	unprognostic (4.33e-4)	unprognostic (1.10e-1)	unprognostic (3.53e-3)		unprognostic (7.76e-3)	unprognostic (1.21e-1)	unprognostic (3.53e-1)	unprognostic (6.82e-3)	unprognostic (5.09e-3)	unprognostic (3.88e-2)	unprognostic (6.46e-2)	unprognostic (3.49e-3)	2.5	0.2	0.4	0.4	0.9	0	23.1	0.4	2	1	0.4	0.4	0.4	0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	5.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.9	0.4	2	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0	0.4	0.1	0	0.2	0	1.4	1.2	0	0	0	0	0	2.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	Alveolar cells type 1
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skeletal muscle: 38.6;smooth muscle: 37.2	Cell type enriched	Detected in some	5	Alveolar cells type 1: 86.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044035, HPA053341	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA044035: AB_10964274, HPA053341: AB_2732578	unprognostic (1.06e-1)				unprognostic (4.36e-2)	unprognostic (3.06e-1)		unprognostic (1.09e-1)			unprognostic (8.56e-4)	unprognostic (1.00e-1)	unprognostic (4.95e-2)	unprognostic (6.05e-3)	unprognostic (2.29e-1)	unprognostic (5.94e-2)	unprognostic (3.20e-2)	22.9	3.1	9.1	3.4	6.9	0	2.8	12.4	21	7.4	12	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0	6.8	1.1	0.9	20.4	5	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0	0	0	0.2	0	0.9	0.1	0	2.9	12.5	0	1.1	3	0	0.3	2.2	1.9	4.5	0	0	0	0	0.4	10.9	0	1.2	0	2.9	0.6	0	0	0	0	0.2	0	0	4.7	0	8.1	0	1.4	0	1.2	0	0.3	2.3	0	4.3	0	4.2	0	0.1	0	2.1	0	0.7	0	31.5	15.6	0	0	0.3	0	0	0.9	0	8.6	1.4	0	2	0	0	0	5	0.2	6.7	0	0.2	0	0	0	0	0	0.9	0.3	0	0	0	0	0	0	0	0	0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2	86.4	19	0	0.1	0	3.3	0	0	6.7	5.7	0	0	0	0	0	1.9	0	0	0	0	0	1.5	0.1	0	0	0.2	7.9	0	1.3	0.8	0	0.9	0	1.7	0	0	0	0	0	0.4	0	1	0	0.2	0.9	0.1	0	0.1	0	0	0	Alveolar cells type 1
AGER	RAGE, SCARJ1	ENSG00000204305	Advanced glycosylation end-product specific receptor	Q15109	6	32180968-32184324	Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Inflammatory response		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	lung: 178.6	Cell type enriched	Detected in many	18	Alveolar cells type 1: 2224.3	Cancer enhanced	Detected in all		lung cancer: 27.2	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1	Low region specificity	Detected in single			Not detected	Not detected			CAB011682, HPA064436, HPA069474	Enhanced		Approved	Nucleoli fibrillar center,Plasma membrane,Cell Junctions	Secreted in other tissues			5360000	140000	Plasma membrane, Cell Junctions	Nucleoli fibrillar center	CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: 	unprognostic (9.37e-2)	unprognostic (3.70e-1)	unprognostic (2.37e-2)	unprognostic (1.14e-1)	unprognostic (4.55e-2)	unprognostic (1.59e-3)	unprognostic (4.36e-2)	unprognostic (1.00e-1)	unprognostic (4.38e-2)	unprognostic (1.27e-1)	prognostic favorable (3.41e-4)	unprognostic (1.24e-1)	prognostic unfavorable (9.01e-7)	unprognostic (3.57e-1)	unprognostic (3.70e-2)	unprognostic (4.44e-2)	prognostic favorable (2.74e-6)	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1	0.3	0.1	0.5	0.1	0.2	0.2	0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0	0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0	0.8	0.2	4.2	0.3	1.5	0	0.2	0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0	1.9	0.1	1.2	0.1	0.2	0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0	0.3	0	0.5	0	0.1	0	0.3	0.2	0	0.7	0.4	0.3	1	0.1	0.2	0.7	0	0.1	0.2	0.2	0.9	0.2	0.2	0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0	0.9	0	1.5	0	2.6	0.5	0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0	2.5	9	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0	0.7	1.6	1.8	5	0.9	0.8	Alveolar cells type 1
CXorf49		ENSG00000215115	Chromosome X open reading frame 49	A8MYA2	X	71714371-71718151	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	58	testis: 5.8	Cell type enriched	Detected in single	12	Alveolar cells type 1: 3.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	A-431: 14.2																																							0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	5.8			0		0	0		0	0	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Alveolar cells type 1
C13orf42	LINC00371	ENSG00000226792	Chromosome 13 open reading frame 42		13	51082119-51200252	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Tissue enriched	Detected in single	5	testis: 3.2	Cell type enriched	Detected in single	5	Alveolar cells type 1: 3.0	Cancer enriched	Detected in single	46	testis cancer: 2.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 11.0;NTERA-2: 13.9;SuSa: 3.4	Not detected	Not detected																								unprognostic (9.77e-2)									unprognostic (5.61e-2)	unprognostic (1.73e-2)			0	0		0		0	0		0.2	0	0			0	0	0	0	0	0	0.2			0.5	0	0.1	0			0	0	0		0		0	0.1		0	0	0	0.4	0	0		0.7	0	3.2			0		0	0		0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0											3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
UPK3B	FLJ32198, MGC10902, p35, UPIIIb	ENSG00000243566	Uroplakin 3B	Q9BT76	7	76510428-76516521	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0	Cell type enriched	Detected in some	10	Alveolar cells type 1: 113.2	Group enriched	Detected in many	12	ovarian cancer: 64.6;urothelial cancer: 78.4	Region enriched	Detected in single	58	pons and medulla: 5.8	Cell type enriched	Detected in single	6	neutrophil: 1.2	Lineage enriched	Detected in single	6	granulocytes: 1.2	Cell line enhanced	Detected in some		A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2									HPA010506	Approved											HPA010506: AB_1080479	unprognostic (8.33e-2)	unprognostic (1.30e-1)	unprognostic (3.62e-3)	unprognostic (2.26e-3)	unprognostic (7.87e-2)	unprognostic (8.60e-2)	unprognostic (1.12e-1)	unprognostic (2.63e-1)	unprognostic (4.03e-1)	unprognostic (5.92e-2)	unprognostic (1.37e-2)	unprognostic (4.06e-2)	unprognostic (8.37e-9)	unprognostic (3.56e-2)	unprognostic (2.01e-1)	unprognostic (1.66e-1)	unprognostic (6.34e-2)	28.5	0.3	0	7.1	0	0.4	0.3	0	0.3	1.5	6.9	0.1	0	0.3	0.8	7.9	40.2	2.8	3	9.4	0	0	0.3	0.4	34.1	0.4	0	0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0	0.2	0.3	6.1	25	20.5	2.1	0	0	1.2	0	0	0.2	0	0.6	7.8	0	0	0	0	0	0	0	0	0	0.1	28.5	0	0.2	0	0	5.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	1.6	0	0	0	0	0	19.5	0	0	0.2	2.3	0	0	16.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	113.2	3.5	0	0.2	1.4	0	0.3	2.5	4	9.1	3.5	3.9	0.1	0	0	0	0.4	0	0	0	0	0.4	0.2	1.1	0	0.1	1.6	0	0.6	0	0	11.2	0.9	3.3	0	0	0.5	0.1	0	0	0	0.1	0	0.1	0	0.1	2.5	0.1	0	0.1	2.5	Alveolar cells type 1
AC133555.3		ENSG00000258150			16	29464967-29467833	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		testis: 9.8	Cell type enriched	Detected in some	7	Alveolar cells type 1: 11.9	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.9;CAPAN-2: 22.0;SK-BR-3: 17.2									HPA053608	Uncertain											HPA053608: AB_2682205										unprognostic (9.92e-2)								1.5	0.2	1.1	0.2	0.3	1.5	1.3	0.1	1.6	0.7	0.8			4.2	1.1	0	0.7	3	4.1	0.8	0.4	1	1.3	0	0.8	3.1	0.5		0.5	0.2	0.2	1.6	0		0.5	0.3		5.1	0.3	0.9	0.6	0.7	0.2	0.3	0.5	0.3	9.8			0.5		0.3	0.3	0.6	0.6	2.5	0.9	2.5	0.2	1.7	0.8	1.4	4.9	0.2	0.1	0.8	0.5	0.6	0.1	0.4	0.4	0.6	0	22	0.7	2.2	0.4	0	1.4	0	0.5	0	0.2	0	0	0	0	0	0	0	1.5	0	1.8	0	0.4	0	0.2	0	0.1	0.8	0.5	0.1	0	0	0.5	0	0.4	0	0.4	2.5	0.2	0	0.3	0	17.2	0	0	0.3	0	0.5	0.6	0.1	0	0	0	0.5	0	1.7	0	0.4	0.6	1.8	0.1	1.7	1.5	0.4	0.6	1.2	0.4	2.5	0.2	0.5	1	0.9	0.2	2.5	0.2	0.8	0.8											11.9	0.6	0	0	0	0	0	0	1.4	1.2	1.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	Alveolar cells type 1
AL132780.3		ENSG00000259132			14	22946270-22982258	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	30	Alveolar cells type 1: 3.0	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 28.1									HPA029803	Approved		Approved	Plasma membrane,Focal adhesion sites						Plasma membrane, Focal adhesion sites		HPA029803: AB_10601428																		4.8	6.2	4.5	4.7	5.5	6.6	5.3	3.5	2.4	16.1	7.1	2.3	7.1	5.5	12.4	9.2	16.2	6.6	11.2	6	4.6	3.8	20.4	24.5	10.5	7.9	5.3	1.9	11.8	13.8	0	3.5	18.1	3.8	13.1	6.1	10.4	5.7	16	6.2	8.8	4.5	3.5	4.5	11.3	4.5	6	1.9	10.3	22.1	7.7	9.6	5	7.9	3.3	5.7	10.2	5.9	1.1	4.1	2.8	4.1	8.9	6.2	2	6.1	7.2	4	0.7	5.8	3.7	3.8	3	3.1	0	2.4	6.8	2.1	1.6	2.9	3.1	2.6	0	0.7	1.3	6.8	28.1	4	3.2	2.6	3.2	8.2	2.9	7	8.1	5.1	7.4	0	6.1	4	16.8	7	12	3	6.9	1.9	3.4	4.4	3.8	10.3	8.4	3.5	2	2.8	3.6	1.7	4.5	5.5	7.1	1	4.7	3.4	1.9	3.5	6	7.3	6.3	1.6	3.2	2.9	0.5	5.9	2.1	2.5	4.2	1.2	2.7	1.8	2.1	5.7	3.3	3.4	1.7	10.2	1.1	2.9	2.6	4.1	2.8	4.5	5.5	3.5	2.4	4.6	3.8	5.3	1.9	3.8	1.9	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
AC099811.2		ENSG00000267261			17	42119674-42154916	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	30	Alveolar cells type 1: 3.0	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MOLT-4: 6.9;REH: 5.0;SK-BR-3: 5.0;U-87 MG: 4.7																																							5.1	4.4	4.5	9.1	5.9	3.4	4.5	6.6	9.5	4.6	4.4	7	2.5	10.4	4	2.9	4	3	3.7	4.1	4.5	5.2	9.7	8.6	7	5.5	5.8	3.6	4	14	2.9	3.2	5.1	5	4	3.5	4.4	3.4	4.7	4.8	4.4	6.2	4.4	3.7	6.4	4.3	4.3	5.2	3.2	7	1.7	4.3	6.2	4.3	0.5	0.7	1.3	1.4	0.2	0.5	0.3	2.6	0	0.9	1.1	0	0	0	0	0	0.7	0.6	0	0	0.3	1	0	2.1	2.6	0	0.7	0	2	1.1	1.3	1.3	1.4	0	0	0	2	0.5	1.3	0	0	0	0.8	0.2	0.9	0	0	6.9	0.1	1.1	2.4	0	5	1.1	0	0	1.3	0.4	2.2	0	5	0.2	1.2	0	0	0	0.9	1.3	0	1.9	2.5	0.7	0	4.7	0	0	0	1.4	0.3	0.3	0.3	0.1	0.2	0.2	0.3	0.6	0.5	0.2	0.3	1.3	0.2	0.2	0.7	0.5	0.3	4.5	5.9	6.6	9.5	4.5	5.2	5.8	3.6	5	5.2	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
